Evidence map›Paper›PMID 41107276›Full record

ArticleSchizophrenia (Heidelberg, Germany)2025

Concept confirmation of the Schizophrenia Cognition Rating Scale (SCoRS) among unpaid and professional caregivers.

Christoph U Correll, Sebastien Tulliez, Maggie Heinrich, Katja Rudell, Alessandra Girardi, Richard Keefe, Abraham Goldring, Corey Reuteman-Fowler

Abstract read
In one paragraph

Article in Schizophrenia (Heidelberg, Germany), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Christoph U CorrellZucker Hillside Hospital, Department of Psychiatry, Northwell Health, Glen Oaks, NY, USA.ORCID http://orcid.org/0000-0002-7254-5646
Sebastien TulliezBoehringer Ingelheim International GmbH, Frankfurt, Germany.
Maggie HeinrichParexel International, London, UK.
Katja RudellParexel International, London, UK.
Alessandra GirardiParexel International, London, UK. Alessandra.Girardi@parexel.com.
Richard KeefeDuke University Medical Centre, Durham, NC, USA.ORCID http://orcid.org/0000-0002-0173-8897
Abraham GoldringEpisteme Inc. NY; Nathan S Kline Institute, Orangeburg, NY, USA.
Corey Reuteman-FowlerBoehringer Ingelheim Pharmaceuticals Inc., Ridgefield, CT, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Schizophrenia is a complex mental health condition characterized by a range of heterogenous symptoms. Cognitive impairment associated with schizophrenia (CIAS) interferes with individuals' ability to manage their daily activities and has a detrimental effect on everyday life. The Schizophrenia Cognition Rating Scale (SCoRS) is an interview-based assessment, which was developed to provide a detailed evaluation of the performance of everyday tasks in the real world. The assessment is completed by clinicians with input from patients with schizophrenia and caregivers. The scale has good psychometric properties and has been used across several trials. Nevertheless, the relevance of the SCoRS from the caregivers' perspective has not been confirmed. The aim of this study was to confirm the content of the SCoRS from the caregivers' perspective. A cross-sectional qualitative study was conducted with primary (live-in, for example, a family member) and secondary (professionally trained) caregivers in the US caring for patients with schizophrenia. The caregiver research confirmed the concepts that clinicians and patients had previously identified in the creation of the PRECIS scale as clear cognitive deficits of patients with schizophrenia. Understanding that family and professional caregivers confirm these cognitive impairments to be real, independently from the patient and clinicians, is helpful to determine the validity of the cognitive impairment concept. Overall, the findings confirmed that the SCoRS captures relevant aspects of cognitive functioning in patients with schizophrenia and support the relevance and clarity of instructions, domains, and items with primary and secondary informants.

Identifiers

PMID41107276
PMCPMC12534470

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.